CLINICAL IMMUNOBIOCHEMICAL MARKERS IN OPTIMIZING THE DIAGNOSTICS OF BRONCHIAL ASTHMA IN COMORBIDITY WITH TYPE 2 DIABETES MELLITUS. (2025). Modern American Journal of Medical and Health Sciences, 1(8), 51-63. https://usajournals.org/index.php/1/article/view/1362